Proteome Sciences plc

LSE:PRM.LHealthcareFTSE:AXX

£0.0121−10.04%Delayed 15 minIn session · ≈ AED 0.0595 · Market cap $5.68M

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	54.0%	57.7%	61.3%	23.1%	−3.4%	−26.8%	—	—
Operating margin	11.2%	10.0%	19.2%	−29.2%	−46.5%	−71.0%	−71.0%	+0.0 pts
Net margin	6.3%	1.4%	17.0%	−48.6%	−69.7%	−81.5%	−81.5%	+0.0 pts
EBITDA margin	14.7%	12.2%	27.3%	−22.6%	−31.0%	−46.3%	—	—
Return on equity	−8.8%	−2.6%	−157.2%	79.7%	52.3%	32.1%	32.1%	+0.0 pts
Return on assets	3.2%	0.7%	10.7%	−21.3%	−37.0%	−37.1%	−37.1%	+0.0 pts
Return on capital employed	−21.0%	−30.6%	−2,660.7%	144.7%	47.3%	32.1%	—	—
Debt / equity	−3.3×	−4.2×	−14.1×	−4.4×	−2.2×	−1.7×	−1.7×	+0.0%
Debt / assets	121.4%	116.3%	95.8%	117.6%	157.7%	191.0%	—	—
Interest coverage	1.7×	1.7×	3.2×	−1.8×	−2.5×	−2.9×	—	—
Current ratio	0.4×	0.4×	0.6×	0.3×	0.2×	0.1×	0.1×	+0.0%
Quick ratio	0.3×	0.3×	0.5×	0.3×	0.1×	0.1×	—	—
Cash ratio	0.2×	0.2×	0.3×	0.2×	0.1×	0.0×	0.0×	+0.0%
Asset turnover	0.5×	0.5×	0.6×	0.4×	0.5×	0.5×	—	—
Inventory turnover	2.5×	2.0×	3.3×	4.6×	6.9×	8.9×	—	—
Receivables turnover	4.2×	5.5×	5.0×	4.8×	9.6×	5.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.